Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-20

Clinical Trial Update: Niclosamide Role in Diabetic Nephropathy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating niclosamide for diabetic nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Niclosamide (niclosamide)

Snippet

Sponsor: Tanta University | Conditions: Diabetic Nephropathies | Phase 3 | Status: COMPLETED